Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
暂无分享,去创建一个
Alexey Sergushichev | Emma E. Vincent | Maxim N. Artyomov | Jeremy M. Tavaré | Takla Griss | E. E. Vincent | Russell G. Jones | M. Gingras | A. Pause | J. Tavaré | D. Elder | B. Samborska | Gäelle Bridon | M. Artyomov | D. Avizonis | A. Sergushichev | J. Blagih | Gaëlle Bridon | Takla Griss | Marie-Claude Gingras | Bozena Samborska | Thierry Ntimbane | Paula P. Coelho | Julianna Blagih | Thomas C. Raissi | Luc Choinière | Ekaterina Loginicheva | Breanna R. Flynn | Elaine C. Thomas | Daina Avizonis | Arnim Pause | Douglas J. E. Elder | Elaine C Thomas | E. Loginicheva | T. Raissi | Thierry Ntimbane | L. Choinière | P. Coelho | B. Flynn | E. Vincent | Ekaterina Loginicheva
[1] Jesse M. Platt,et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.
[2] LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancer , 2013, Cancer & metabolism.
[3] Christian M. Metallo,et al. Regulation of substrate utilization by the mitochondrial pyruvate carrier. , 2014, Molecular cell.
[4] M. Suematsu,et al. HIF-1alpha is necessary to support gluconeogenesis during liver regeneration. , 2009, Biochemical and biophysical research communications.
[5] M. Prentki,et al. A Role for ATP-Citrate Lyase, Malic Enzyme, and Pyruvate/Citrate Cycling in Glucose-induced Insulin Secretion* , 2007, Journal of Biological Chemistry.
[6] E. E. Vincent,et al. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. , 2015, Immunity.
[7] D. Sabatini,et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides , 2014, Nature.
[8] Takla Griss,et al. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α , 2014, Proceedings of the National Academy of Sciences.
[9] B. Faubert,et al. PGC-1α supports glutamine metabolism in breast cancer , 2013, Cancer & Metabolism.
[10] K. Vousden,et al. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. , 2014, Cell reports.
[11] A. Harris,et al. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer , 2014, Oncogene.
[12] Ralph J Deberardinis,et al. Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.
[13] Takla Griss,et al. Differential effects of AMPK agonists on cell growth and metabolism , 2014, Oncogene.
[14] J. Urbina,et al. Inhibition of phosphoenolpyruvate carboxykinase from Trypanosoma (Schizotrypanum) cruzi epimastigotes by 3-mercaptopicolinic acid: in vitro and in vivo studies. , 1990, Archives of biochemistry and biophysics.
[15] R. Kibbey,et al. The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked? , 2014, Biochimica et biophysica acta.
[16] Gregory Stephanopoulos,et al. Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.
[17] Christian M. Metallo,et al. Mitochondria as biosynthetic factories for cancer proliferation , 2015, Cancer & metabolism.
[18] Takashi Tsukamoto,et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.
[19] Eyal Gottlieb,et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2 , 2012, Nature.
[20] R. Deberardinis,et al. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. , 2009, Cancer research.
[21] Min Jung Park,et al. Molecular mechanism of hypoxia‐mediated hepatic gluconeogenesis by transcriptional regulation , 2005, FEBS letters.
[22] R. Bernards,et al. MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling , 2012, Cell.
[23] Takla Griss,et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. , 2013, Cell metabolism.
[24] Abhishek K. Jha,et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. , 2015, Immunity.
[25] D. Valenti,et al. The role of mitochondrial transport in energy metabolism. , 2003, Mitochondrion.
[26] E. E. Vincent,et al. Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation , 2014, PloS one.
[27] L. Boros,et al. Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[28] G. Shulman,et al. Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion , 2009, The Journal of Biological Chemistry.
[29] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[30] Jessica E. S. Shay,et al. Effects of hypoxia and HIFs on cancer metabolism , 2012, International Journal of Hematology.
[31] M. V. Vander Heiden,et al. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.
[32] 이연수. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .
[33] Beatriz Pardo,et al. Mitochondrial transporters as novel targets for intracellular calcium signaling. , 2007, Physiological reviews.
[34] D. Sabatini,et al. Cancer cell metabolism: one hallmark, many faces. , 2012, Cancer discovery.
[35] M. Tomita,et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. , 2009, Cancer research.
[36] R. Deberardinis,et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. , 2014, Molecular cell.
[37] E. E. Vincent,et al. Overexpression of the TXNDC5 protein in non-small cell lung carcinoma. , 2011, Anticancer research.
[38] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[39] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[40] Christian M. Metallo,et al. Metabolic pathway alterations that support cell proliferation. , 2011, Cold Spring Harbor symposia on quantitative biology.
[41] L. Cantley,et al. Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. , 2015, Cancer research.
[42] Giulia Guzzo,et al. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation , 2014, Oncotarget.
[43] D. Dang,et al. Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes , 2010, Molecular Cancer.
[44] W. Marston Linehan,et al. Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.
[45] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[46] Christian M. Metallo,et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.
[47] J. Locasale. Serine, glycine and one-carbon units: cancer metabolism in full circle , 2013, Nature Reviews Cancer.
[48] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.